Success Stories: EB-1A Approved for a Research Associate in Illinois in the Field of Cell Biology
Client’s Testimonial:
I am so glad to hear about it! Thanks for your great help!
Position at the Time of Case Filing: Research Associate
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Illinois
Approval Notice Date: September 4, 2014
Processing Time: 6 Months, 16 Days
In this case, the client that we had the pleasure of working with was a Research Associate from China in the field of Cell Biology. Her specialized research has focused on the study of various molecular pathways to uncover novel therapeutics for the treatment of cancer as well as HIV-associated neurological disorders. Her work had resulted in at least 13 peer-reviewed scientific articles published in leading journals, 1 patent, and numerous presentations at national and international conferences and seminars. At the time that her case was filed, her publications had been cited at least 174 times by researchers around the world, serving as apparent and objective evidence of her major influence and impact on the field of endeavor, in addition to her sustained international acclaim. She had also conducted 17 manuscript reviews for at least 9 distinctive, internationally circulated journals. Her superior level of expertise was confirmed in the following quote from an independent recommender, “[Client] is at the forefront of her field and without her continued studies, progress in disease treatment, including HIV and cancer, would be compromised. Currently, there are 1.1 million Americans living with AIDS and over 12,000,000 who have been diagnosed with cancer. I am confident that if allowed, [client] will continue to make great strides in her field to the interest of millions of Americans.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of Cell Biology, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in 6 months and 16 days.